Literature DB >> 11793464

Refractive anomalies and visual activation in functional magnetic resonance imaging (fMRI): a versatile and low-cost MR-compatible device to correct a potential confound.

Gregor-K Elbel1, Christian Kaufmann, Stefan Schaefers, Anne Buser, Dorothee P Auer.   

Abstract

PURPOSE: To develop a magnetic resonance (MR)-compatible, versatile, easy-to-use, and low-cost device for refractive correction.
MATERIALS AND METHODS: We retrospectively evaluated the application and practicability of the refractive correction in 110 subjects who had participated in various functional MR imaging (fMRI) studies with complex visual stimulation paradigms since the introduction of the MR-compatible lens frame at our site. The subjects consisted of 31 patients with Parkinson's disease (age range, 40-85; mean age, 63.2 years) and 79 healthy volunteers (age range, 18-79; mean age, 46.7 years).
RESULTS: In volunteers, experimentally induced myopia caused a substantial (>20%) reduction of the blood oxygenation level dependent (BOLD) response to a flickering dartboard.
CONCLUSION: Refractive errors (and the resulting optical blur) may play a nonnegligible role as a possible interfering factor in fMRI experiments with visual stimuli. The MR-compatible frame (fitted with appropriate lenses) used in this study affords full refractive correction at reasonable cost and preparation time. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2002        PMID: 11793464     DOI: 10.1002/jmri.10031

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  2 in total

1.  Effect of lens-induced myopia on visual cortex activity: a functional MR imaging study.

Authors:  A Mirzajani; E Sarlaki; H H Kharazi; M Tavan
Journal:  AJNR Am J Neuroradiol       Date:  2011-08-04       Impact factor: 3.825

2.  Effects of refractive errors on visual evoked magnetic fields.

Authors:  Masaya Suzuki; Mizuki Nagae; Yuko Nagata; Naoya Kumagai; Koji Inui; Ryusuke Kakigi
Journal:  BMC Ophthalmol       Date:  2015-11-09       Impact factor: 2.209

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.